Trial
NCT02066311
Nelfinavir in Systemic Lupus Erythematosus
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Condition
Systemic Lupus Erythematosus
Intervention
Nelfinavir
Why stopped
Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-24